Gene · 4200
Papers3,297
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,297
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characterization and Inhibition of the Chaperone Function of Plasmodium falciparum Glucose-Regulated Protein 94 kDa (Pf Grp94). | Proteins | 2025 | 39670568 | PubTator, text mining | PubMed |
| PGC-1α Promotes mitochondrial biosynthesis and energy metabolism of goose fatty liver. | Poult Sci | 2025 | 39644719 | PubTator, text mining | PubMed |
| Identifying clinical and proteomic markers for early diagnosis and prognosis prediction of major psychiatric disorders. | J Affect Disord | 2025 | 39426510 | PubTator, text mining | PubMed |
| ME2 Deficiency Is Associated With Recessive Neurodevelopmental Disorder. | Clin Genet | 2025 | 39401966 | PubTator, text mining | PubMed |
Effects of four-week lasting aerobic treadmill training on hepatic injury biomarkers, oxidative stress parameters, metabolic enzymes activities and histological characteristics in liver tissue of hyperhomocysteinemic rats. | Mol Cell Biochem | 2025 | 39384708 | PubTator, text mining | PubMed |
| A Collection of Useful Nuisance Compounds (CONS) for Interrogation of Bioassay Integrity. | JACS Au | 2024 | 39735938 | PubTator, text mining | PubMed |
| ANGPTL4 mediated mesothelial-mesenchymal transition in pulmonary fibrosis: a potential therapeutic target. | J Transl Med | 2024 | 39707362 | PubTator, text mining | PubMed |
| A Targeted Octahedral DNA Nanostructure Co-delivers siME3 and Doxorubicin to Enhance Collateral Lethality in ME2-Deficient Pancreatic Cancer. | Nano Lett | 2024 | 39602246 | PubTator, text mining | PubMed |
| Drug Discovery in the Age of Artificial Intelligence: Transformative Target-Based Approaches. | Int J Mol Sci | 2024 | 39596300 | PubTator, text mining | PubMed |
| PRMT1-mediated methylation of ME2 promotes hepatocellular carcinoma growth by inhibiting ubiquitination. | Cell Death Dis | 2024 | 39528487 | PubTator, text mining | PubMed |
| N-glycoproteomic and proteomic alterations in SRD5A3-deficient fibroblasts. | Glycobiology | 2024 | 39360848 | PubTator, text mining | PubMed |
| Design Glutamate Dehydrogenase for Nonaqueous System by Motifs Reassembly and Interaction Network Analysis. | J Agric Food Chem | 2024 | 39222309 | PubTator, text mining | PubMed |
| Effects of protein variations by different extraction and dehydration approaches on hempseed protein isolate: Protein pattern, amino acid profiling and label-free proteomics. | Food Chem | 2024 | 39047496 | PubTator, text mining | PubMed |
| A survey of generative AI for de novo drug design: new frontiers in molecule and protein generation. | Brief Bioinform | 2024 | 39007594 | PubTator, text mining | PubMed |
| Roles of the oncometabolite enantiomers of 2-hydroxyglutarate and their metabolism by diverse dehydrogenases. | Essays Biochem | 2024 | 38919140 | PubTator, text mining | PubMed |
| Resolving Challenges in Detection and Quantification of D-2-hydroxyglutarate and L-2-hydroxyglutarate via LC/MS. | bioRxiv | 2024 | 38903117 | PubTator, text mining | PubMed |
| Privileged proteins with a second residence: dual targeting and conditional re-routing of mitochondrial proteins. | FEBS J | 2024 | 38857249 | PubTator, text mining | PubMed |
| Mammalian target of differentiation-inducing factor-1 is mitochondrial malate dehydrogenase for activation of AMP-activated protein kinase and induction of mitochondrial fission. | Life Sci | 2024 | 38852800 | PubTator, text mining | PubMed |
| Stomatal response to VPD in C4 plants with different biochemical sub-pathways. | Plant Cell Environ | 2024 | 38752440 | PubTator, text mining | PubMed |
| Natalizumab promotes anti-inflammatory and repair effects in multiple sclerosis. | PLoS One | 2024 | 38527011 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4200/papers?page=6